Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

NCT02227667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: MEDI4736

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]
[object Object]